MF
UTHR icon

Magnetar Financial’s United Therapeutics UTHR Stock Holding History

Magnetar Financial’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7,988
Closed -$2.46M – 1163
2025
Q1 		$2.46M Buy
+7,988
New +$2.74M 0.03% 254
2023
Q2 		– Sell
-3,189
Closed -$714K – 624
2023
Q1 		$714K Buy
+3,189
New +$786K 0.01% 425
2022
Q2 		– Sell
-4,882
Closed -$876K – 1831
2022
Q1 		$876K Buy
4,882
+3,366
+222% +$641K 0.01% 821
2021
Q4 		$328K Sell
1,516
-1,543
-50% -$303K ﹤0.01% 1047
2021
Q3 		$565K Sell
3,059
-61
-2% -$12K 0.01% 858
2021
Q2 		$560K Buy
+3,120
New +$594K 0.01% 855
2020
Q4 		– Sell
-16,940
Closed -$1.71M – 897
2020
Q3 		$1.71M Buy
+16,940
New +$1.86M 0.03% 271
2019
Q3 		– Sell
-2,607
Closed -$204K – 586
2019
Q2 		$204K Buy
+2,607
New +$244K ﹤0.01% 404
2015
Q3 		– Sell
-1,188
Closed -$207K – 521
2015
Q2 		$207K Buy
+1,188
New +$214K ﹤0.01% 412

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Magnetar Financial's UTHR Position: Q2 2025 in Review

Magnetar Financial sold out of United Therapeutics (UTHR) in Q2 2025, closing a stake of 7,988 shares — an estimated $2.46M sold.

Magnetar Financial first reported a position in UTHR in Q2 2015 and held it in 9 quarters. The position peaked at $2.46M in Q1 2025. 671 funds tracked by Wall St. Rank hold UTHR as of Q2 2025.

  • Magnetar Financial reported no remaining United Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Magnetar Financial sold 7,988 United Therapeutics shares in Q2 2025, an estimated $2.46M.
  • Magnetar Financial first reported a position in United Therapeutics in Q2 2015 and held it in 9 quarters.
  • Magnetar Financial's United Therapeutics position peaked at $2.46M in Q1 2025.
  • 671 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2025.

Based on Magnetar Financial's 13F filing for Q2 2025, filed 12 Aug 2025.